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Abstract: 
 
Purpose: Microbicide effectiveness for HIV/STI prevention may require specific timing of 
application in relationship to coitus. We examined actual timing of use of a microbicide 
surrogate (vaginal moisturizer [VM]) compared to assigned timing condition among young 
women. 
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Article: 
 
Purpose: Microbicide effectiveness for HIV/STI prevention may require specific timing of 
application in relationship to coitus. We examined actual timing of use of a microbicide 
surrogate (vaginal moisturizer [VM]) compared to assigned timing condition among young 
women. 
 
Methods: Young women were asked to use a VM (pre-filled, disposable applicator) with each 
coital act during one month cycles (every six months) in a random timing sequence—1 hour pre-
coitus, 10 minutes pre-coitus, and 10 minutes post-coitus. Daily diaries collected information 
related to coital behaviors, VM use and timing, and young women's and partners attitudes toward 
VM use. Descriptive and mixed-effects model analyses were conducted that accounted for the 
repeated subject effect. 
 
Results: 109 women (18-22 years old) completed at least 3 VM diary cycles. Of the 17,772 diary 
days collected, coitus was reported on 2128 days (1252 with VM use; 59%). The median time 
between VM application and coitus for the 1 hour pre-coital group was 60 minutes (range: 2+ 
hours pre-coitus to 1-10 minutes post-coitus) and the median for the 10 minute pre-coital group 
was 13.5 minutes (range: 2+ hours pre-coitus to 1-10 minutes post-coitus). The median for the 
10 minute post-coital group was 5 minutes pre-coitus (range: 2+ hours pre-coitus to 1+ hour 
post-coitus). The 1-hour pre-coitus and the 10-minute pre-coitus groups both had significantly 
smaller standard deviations than the post-coital group (t = 4.45 and 2.22, respectively). In the 
10 minute post-coital group 65% (286/443) of VM use was pre-coital and 18% (78/443) was 30 
or more minutes post-coital. The VM was used within 30 minutes before coitus in about half of 
the events (n = 513); in the majority of these events women reported the VM was very easy to 
use (n = 365); somewhat messy (n = 316); that they were very wet during sex (n = 422); and that 
the sex was very good (n = 400). In addition, women reported that their partners liked using the 
VM (n = 220). 
 
Conclusions: Overall there was tremendous variation in timing of VM application during the 
59% of coital events in which it was used. Although median time values of actual VM use 
accurately reflected assigned timing condition in the pre-coital groups, there was substantial 
deviation in application time across the three timing conditions with significantly greater 
variability in the post-coital group. While VM use was positively rated in terms of ease of 
use and feeling during coitus; these results have implications for behavioral challenges related to 
specific timing requirements for microbicide application, especially for young women. For 
instance, it is often difficult to accurately estimate when coitus will occur, making pre-coital 
application difficult while post-coital application necessitates having the microbicide accessible. 
These findings suggest that targeted educational efforts will need to be directed at young people, 
including messages about the increased comfort with use, in order to increase the likelihood that 
future microbicides will be used at appropriate times to optimize HIV/STI prevention 
effectiveness. 
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